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TNF-aAbstract Background: In juvenile idiopathic arthritis (JIA) several proinﬂammatory cytokines are
secreted leading to anorexia and weight loss.
Objectives: We aimed to measure serum levels of ghrelin, adipocytokines and tumor necrosis factor
alpha (TNF-a) in JIA patients. Also, to correlate them with disease activity and patients’ body mass
index (BMI).
Patients and methods: Sixty-ﬁve patients with JIA (40 girls and 25 boys; means ± SD of age were
12.1 ± 3.5 years) and 54 matched healthy controls were evaluated by ELISA to measure levels of
ghrelin, leptin, adiponectin and TNF-a and correlate these levels with Juvenile Arthritis Disease
Activity Score (JADAS) and patients’ BMI.
Results: Thirty-four patients (52.3%) had active disease while 31 (47.7%) had inactive disease. JIA
patients had signiﬁcantly lower level of ghrelin and leptin and signiﬁcantly higher level of TNF-a
than the control group (P 6 0.001, P 6 0.05, P 6 0.001, respectively). Those with active disease
had signiﬁcantly lower level of ghrelin and signiﬁcantly higher TNF-a level than those with inactive
disease (P 6 0.001, P 6 0.01, respectively). Signiﬁcant positive correlations were found between
ghrelin and leptin levels and patients’ BMI (P 6 0.05, P 6 0.01, respectively).
Serum levels of ghrelin, adipokines, and tumor necrosis factor-a (TNF-a) 53Conclusion: Ghrelin and leptin could be considered to be responsible for decreased BMI in patients
with JIA, so they might be potential targets of new therapeutic strategies for correction of anorexia
and associated weight loss in those patients. Low ghrelin and high TNF-a could be used as useful
tools in monitoring disease activity in JIA.
ª 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of The Egyptian Pediatric
Association. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).Introduction
Juvenile idiopathic arthritis (JIA) is a term that collectively
refers to a group of chronic arthropathies, which together con-
stitute the most common rheumatic condition in children. It is
also an inﬂammatory joint disease characterized by chronic
synovitis and associated with extra-articular manifestation
such as, fever, anorexia, weight loss, anemia, lymphadenopa-
thy, pericarditis, and uveitis.1
Ghrelin, a recently discovered hormone, is produced pri-
marily by cells in the stomach but is also expressed in white
adipose tissue.2 It has been shown to affect a number of differ-
ent systems including growth hormone release, feeding, gastric
acid secretion, gastric motility, and cell proliferation. Ghrelin
and its receptor have been identiﬁed in T cells. It is a potent
anti-inﬂammatory mediator in lymphocytes, monocytes and
dendritic cells. It inhibits oxidative stress, cellular apoptosis,
cell adhesion and proinﬂammatory cytokine expression and
promotes IL-10 expression and cell migration.3
Adipokines (adipose tissue cytokines), including leptin and
adiponectin are emodeling hormones produced mainly by adi-
pose tissue. Leptin regulates food intake and energy balance. It
is now regarded as a pivotal factor in the interplay between
neuroendocrine function and the immune system.4,5
Proinﬂammatory cytokines increase circulating leptin, which
in turn triggers cytokine release in monocytes/macrophages
and stimulates T cell-mediated immunity during acute inﬂam-
mation.6,7 However, leptin may also limit the inﬂammatory
response.8,9
Adiponectin, is postulated to be associated in the modula-
tion of inﬂammatory responses as it attenuates the inﬂamma-
tory response mediated by TNF-a, inhibits macrophage
phagocytic activity and TNF-a production.10
Cytokines are directly implicated in many of the immune
processes that are associated with the pathogenesis of JIA.
The most important proinﬂammatory cytokines produced by
phagocytes are tumor necrosis factor alpha (TNF-a), IL-1
and IL-6; the key cytokines that drive inﬂammation in JIA.11
TNF-a is a proinﬂammatory cytokine produced as a mem-
brane-bound 26 kDa molecule from which the soluble 17 kDa
active TNF-a molecule is released by the TNF-a converting
enzyme.12 The circulating TNF-a levels are highly variable.13
Also, TNF-a is involved in several biologic processes such as
tissue emodeling, epithelial cell barrier permeability, macro-
phage activation, recruitment of inﬂammatory cells, effective-
ness of the local and systemic inﬂammation and
ampliﬁcation of other proinﬂammatory cytokine actions.14–16
Anorexia and weight loss are consistent clinical manifesta-
tions during acute and chronic inﬂammatory processes, which
are accompanied by decreased quality of life and survival.
These changes are generally attributed to the increased levelsof circulating cytokines such as TNF-a, interleukins 1 (IL1)
and 6 (IL6).1
As JIA is an inﬂammatory disease that is frequently accom-
panied by anorexia and weight loss to our knowledge there are
a few studies regarding serum level of ghrelin and adipokines,
which is related to appetite and inﬂammation. So, the aim of
our study is to investigate circulating serum level of ghrelin
and adipose tissue cytokines (leptin, adiponectin) and a
proinﬂammatory cytokine (TNF-a) in JIA patients. Also to
correlate these levels with Juvenile Arthritis Disease Activity
Score (JADAS) and patients’ BMI.Patients and methods
Sixty-ﬁve patients with JIA (40 girls and 25 boys) aged from 4
to 16 years and have disease duration ranging from 2 to
144 months were enrolled in this study. They were selected
from Rheumatology & Rehabilitation and Pediatric
Departments in Assuit University Hospitals. Classiﬁcation of
JIA patients was done according to The International
League of Associations for Rheumatology (ILAR) criteria.17
Treatment of JIA patients with disease-modifying antirheu-
matic drugs (DMARDS) and suitable dosage of nonsteroidal
anti-inﬂammatory drugs (NSAIDS) during the study was
allowed. Fifty-four healthy children matched with the patients
according to age, sex were recruited as control group.
Exclusion criteria Patients having diabetes mellitus, endocr-
inal disease (Cushing syndrome, thyroid diseases), patients
taking corticosteroid during the last 6 months and those hav-
ing any malignancy were excluded.
Informed consent was obtained from all children’s parents
and the study approved by ethics committee of faculty of med-
icine, Assiut University.
All patients and controls were subjected to the following
A. Detailed history taking.
B. Rheumatologic and systemic examination.
C. BMI was calculated as weight [in kilograms] divided by
squared height [in meters] (kg/m2). BMI below 5th per-
centile reﬂects underweight, BMI between 5th and 84th
percentile reﬂects normal weight, BMI between 85th per-
centile and 94th percentile reﬂects at risk for overweight
and BMI above 95th percentile reﬂects overweight.18
D. Assessment of JIA activity (in patients): by Juvenile
Arthritis Disease Activity Score (JADAS).19,20
E. Laboratory assessment: complete blood count (CBC),
erythrocyte sedimentation rate (ESR), C-reactive pro-
tein (CRP), measurement of serum ghrelin, leptin, adi-
ponectin and TNF-a.
Table 1 Characteristics of the studied patients with juvenile
idiopathic arthritis.
Variable Patients (n= 65)
No. (%)
Age (years)
Mean ± SD (range) 12.1 ± 3.5 (4–16)
Sex
Males 25 (38.5)
Females 40 (61.5)
Pattern of JIA
Systemic onset 16 (24.6)
Polyarticular 16 (24.6)
Oligoarticular 14 (21.5)
ERA* 15 (23.1)
Psoriatic arthritis 4 (6.2)
Disease duration (months)
Mean ± SD (range) 49.6 ± 34.5 (2–144)
Activity
Active 34 (52.3)
Not active 31 (47.7)
* ERA, enthesitis related arthritis.
54 Z.I. Selim et al.6 ml of venous blood was withdrawn from each individual
participating in the study and was divided as follows: 3 ml in
vacutainer tubes with EDTA anticoagulant which were cen-
trifuged immediately at 3000 rpm for 10 min for quantitative
measurement of human unacylated ghrelin in plasma
(Biovender RD, France). The other 3 ml of blood was trans-
ferred to a wassermann tube from which the separated serum
was divided into aliquots and stored at 80 C (for not more
than 2 months) for further estimation of active human leptin
by ELISA (Diagnostic System Laboratories, Inc.), human adi-
ponectin by ELISA (Orgenium, Finland) and TNF-a done by
ELISA (Biosource, Europe SA) according to the manufac-
turer’s instructions.
Statistical analysis
Statistical analysis was performed using SPSS software (ver-
sion 16). The values are expressed as mean ± SD, median,
or percentage as appropriate. For comparison between groups,
Chi square test was used for categorical variables, unpaired
T-test and Mann–Whitney U-test was used for numerical
variables. Spearman’s rho correlation was used to assess the
relationship between laboratory parameters. Differences were
considered signiﬁcant at P< 0.05.
Results
Table 1 shows the demographic characteristics of JIA patients.
The mean ± SD of age were 12.1 ± 3.5 years, females pre-
dominate (61.5%), the type of JIA onset were 16 patients
(24.6%) with systemic onset, 16 (24.6%) polyarticular, 14
(21.5%) oligoarticular, 15 (23.1%) enthesitis related arthritis
(ERA) and 4 (6.2%) psoriatic arthritis. Disease duration
mean ± SD was 49.6 ± 34.5. Regarding activity of the disease
34 patients (52.3%) had active disease while 31 (47.7%) had
inactive disease.
Table 2 shows serum levels of ghrelin, leptin, adiponectin,
and TNF-a in patients (active and inactive) and controls. It
reveals that JIA patients had signiﬁcantly lower serum levels
of ghrelin and leptin and signiﬁcantly higher TNF-a level than
the control group (P 6 0.001, P 60.05, P 6 0.001, respec-
tively), while there was no signiﬁcant difference regarding
serum level of adiponectin in JIA patients and controls. In
addition, Table 2 also shows signiﬁcantly lower ghrelin level
and signiﬁcantly higher TNF-a level in those with active dis-
ease than in those with inactive disease (P 6 0.001, P 6 0.01,
respectively), while no signiﬁcant difference was detected
between them regarding serum levels of leptin and adiponectin.
Fig. 1 clariﬁes the body mass index of patients and controls.
It reveals that by calculating BMI for patients and controls,
47.1%, 64.5% and 75.9% of those patients with active, inac-
tive disease and controls respectively have normal weight
(BMI 5th–84th percentile) while 52.9%, 35.5% and 9.3% of
them respectively have underweight (BMI less than 5th per-
centile). At risk for overweight (BMI 85th–94th percentile)
and overweight (BMI more than 59th percentile) were
observed only in 14.8% of controls and not in patients.
Table 3 summarizes the correlations between ghrelin, lep-
tin, adiponectin and TNF-a levels with BMI. It reveals signif-
icant positive correlations between ghrelin and leptin with
BMI (P 6 0.05, P 6 0.01, respectively) while no signiﬁcantcorrelation was found between adiponectin and TNF-a with
BMI.
Discussion
Ghrelin is a powerful, endogenous orexigenic peptide. In addi-
tion, ghrelin has anti-inﬂammatory effects, and it has been
reported that ghrelin down-regulates pro-inﬂammatory cytoki-
nes, including interleukin (IL)-1 beta and TNF-a.21
Li et al. demonstrated that ghrelin attenuated TNF alpha
induced nuclear translocation NF-jB, indicating that blockade
for activation of the transcription factor NF-jB could be a
potential mechanism whereby ghrelin modulates inﬂammatory
responses.22
Our study demonstrated signiﬁcantly decreased serum level
of circulating ghrelin in patients with JIA compared to con-
trols, in addition those with active disease had signiﬁcantly
lower level of ghrelin than those with inactive disease, and
serum ghrelin was found to be correlated positively with
BMI in patients with JIA. In agreement with our results,
Karagiozoglou et al. reported decreased ghrelin level in
patients with juvenile idiopathic arthritis, and also showed a
signiﬁcant relationship between ghrelin and disease activity,
but they did not ﬁnd a signiﬁcant relationship between ghrelin
and nutritional status,23 while El-Eshmawy et al. reported neg-
ative correlation between serum ghrelin and BMI of Egyptian
adolescents.24 Our data indicate that ghrelin may play an
important role in ameliorating pathologic inﬂammatory states.
Contradictory to our results, Sanem Eren et al. demon-
strated no signiﬁcant difference between JIA patients and con-
trols as regards serum level of ghrelin25 and Koca et al.21 did
not ﬁnd signiﬁcant relation between serum level of ghrelin
and disease activity in patients with JIA.
Other researchers have found signiﬁcant decreased ghrelin
levels in patients with rheumatoid arthritis and in a rat
Table 2 Serum levels of ghrelin, leptin, adiponectin, and TNF-a in patients (active and inactive) and controls.
Studied
parameter
Mean ± SD
Range
Patients Controls
(No. = 54)
P value
Active JIA
(No. = 34)
Inactive JIA
(No. = 31)
Total patients
(No. = 65)
Patients vs
controls
Active JIA vs
inactive JIA
Ghrelin (pg/ml) 30.2 ± 4.5 45.3 ± 8.3*** 37.4 ± 10.1 112.9 ± 15.7*** <0.001 <0.001
23.0–42.0 29.0–65.0 23.0–65.0 75.0–137.0
Leptin (ng/ml) 19.2 ± 6.2 18.8 ± 4.9 19.0 ± 5.6 22.3 ± 8.1* <0.05 NS
9.2–30.0 10.0–29.0 9.2–30.0 7.3–42.5
Adiponectin
(lg/ml)
64.2 ± 20.1 64.5 ± 19.7 64.3 ± 19.8 67.2 ± 17.9 NS NS
27.7–89.0 24.0–88.6 24.0–89.0 24.0–89.4
TNF-a (pg/ml) 48.5 ± 6.7 43.6 ± 4.9** 46.2 ± 6.4 25.9 ± 2.8*** <0.001 <0.01
35.0–61.0 36.7–52.2 35.0–61.0 20.5–30.3
*P< 0.05, **P< 0.01, ***P< 0.001, NS=Non signiﬁcant.
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Figure 1 Body mass index of juvenile idiopathic arthritis patients (active and inactive) and controls.
Table 3 Correlations between ghrelin, leptin and TNF-a,
adiponectin with body mass index (BMI) in studied patients.
BMI
r-Value P-value
Ghrelin (pg/ml) 0.273 <0.05
Leptin (ng/ml) 0.545 <0.001
Adiponectin (lg/ml) 0.088 0.487
TNF-a (pg/ml) 0.36 0.776
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ghrelin concentrations could reﬂect the presence of an inhibi-
tory anorexigenic signal/s.21,26
Leptin is a novel proinﬂammatory adipocyte derived factor
that operates in the cytokine network by linking immune and
inﬂammatory processes to the neuroendocrine. A positive cor-
relation between BMI and circulating leptin concentration hasbeen previously reported in Egyptian patients with growth
delay24 or with JIA.27,28
Our study demonstrated decreased serum level of leptin in
patients with JIA than controls and no relation was detected
with disease activity but a signiﬁcant positive correlation was
detected between serum leptin level in JIA patients and their
BMI. In agreement with our results, other studies demon-
strated that plasma leptin in JIA patients was signiﬁcantly
lower than in controls.1,25 Also previous researchers men-
tioned that circulating leptin concentration was not related
to the activity of the disease but signiﬁcantly related to BMI
of JIA patients either white children1 or Egyptian adults.28
The results of the present study came also in accordance
with Popa et al.29, Lago et al.30 and Gunaydin et al.31 who con-
cluded that serum leptin in RA patients reﬂects BMI but not
joint inﬂammation. These ﬁndings of low leptin in patients
which is not associated with increased weight could be
explained by the suggestion that hypothalamus had been made
insensitive to the low leptin level by the effect of
56 Z.I. Selim et al.proinﬂammatory cytokines which may mime the hypothalamic
effect of excessive negative feedback signaling from leptin,
leading to the prevention of the normal compensatory mecha-
nisms in the face of both decreased food intake and body
weight.1 On the contrary, Agata et al.32 reported that leptin
concentration in sera of JIA children was higher than in
healthy children, also mentioned that in JIA children with high
disease activity leptin concentration was higher than in
children with low disease activity, but without statistical signif-
icance. However, they found a positive correlation between
serum leptin concentration and BMI of their patients and con-
cluded that high leptin concentration in JIA children and its
correlation with BMI could indicate leptin’s role in body mass
regulation in the course of the chronic inﬂammatory process.
Some researchers also reported higher level of leptin in adult
Egyptian patients with JIA than in controls.33,34 Abdalla
et al. reported a positive correlation between leptin level and
BMI of Egyptian adults with JIA but no correlation was found
between leptin and disease activity.34 Winiarska et al. reported
no signiﬁcant difference in serum level of leptin between JIA
patients and controls.35 From the results of these conﬂicting
reports, leptin may inﬂuence JIA in opposing ways: the expres-
sion of cytokines or limiting the inﬂammatory responses, leptin
may be a marker of nutritional status in JIA patients.
Our results demonstrated no signiﬁcant difference in serum
level of adiponectin in patients with JIA and healthy controls,
also no signiﬁcant difference in serum level of adiponectin in
those with active disease and inactive disease. No correlation
was found between serum level of adiponectin in patients with
JIA and their BMI. Our results were in agreement with some
researchers who reported normal adiponectin level in JIA
patients35–37, while others found that level of adiponectin in
JIA patients was lower than in controls and related this to
the inhibition of adiponectin production per unit of fat mass
in the existence of the disease.25 Similar to our results, Patjas
et al. found no signiﬁcant relation between serum adiponectin
level in JIA patients and disease activity. Stepniak et al. found
normal adiponectin level in JIA patients and did not ﬁnd a
relation between their BMI and adiponectin level.38
Contradictory to our results, Alkady et al. reported that serum
adiponectin was higher in 70 Egyptian adult patients with
rheumatoid arthritis than controls and was higher in 39
patients with active disease and reported also that adiponectin
was positively correlated with disease activity.39
Fantuzzi et al. reported that proinﬂammatory cytokines
including TNF and IL-6 inhibit the production of adiponectin.
Also reported that adiponectin may have a role in modulating
the inﬂammatory response by inhibiting the expression of
adhesion molecules on endothelial cells, suppressing macro-
phage function and inhibiting NF-jB signaling.40
In this study TNF-a in JIA patients was signiﬁcantly higher
than in the control group, also it was signiﬁcantly higher in
those patients with active disease than in those with inactive
disease. No signiﬁcant correlation was found between TNF-a
and BMI of JIA patients. These results were in agreement with
previous researchers who concluded that in Egyptian JIA
patients TNF-a is signiﬁcantly higher than in controls.41,42
Also researchers reported higher levels in those with active dis-
ease.42,43 TNF-a is involved in the pathogenesis of JIA.44 Our
results were contradictory to Spirchez et al. as they found no
correlation with disease activity in JIA patients.45Limitations of the study
The following points could be considered as limitations of the
study:
– Not taking into consideration the disease activity score
values.
– Not taking into consideration the JIA subtypes.
– Not presenting the results according to the gender in the
JIA patients.
Conclusion and recommendations
Ghrelin and leptin could be considered to be partially respon-
sible for weight loss in JIA, low ghrelin and high TNF-a could
be considered useful tools in monitoring disease activity in
JIA. We need further studies on larger scales as regards study-
ing ghrelin and leptin as potential targets of new therapeutic
strategies for correction of anorexia and associated weight loss
in those patients with JIA.Conﬂict of interest
None declared.References
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